Home / In the News
Biosimilars Council works to ensure a positive environment for patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/0jAeG0TOPj
Build Back Better aims to reduce drug prices, but its short-term solution would only damage the #biosimilars industry in the long run and reduce access for America's patients.
Learn more to see how this bill could undermine patients' access to care: https://bit.ly/2ZyFYFA
601 New Jersey Ave NW, Suite 850
Washington DC 20001
E: [email protected]
Sign up for our Newsletter
©2020 Biosimilars Council
Biosimilars Council is a division of the Association for Accessible Medicines.